The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Human Molecular Genetics

• Publication date

  2014-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddu081PMID 24594842PMCID PMC4065149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone acetylation: molecular mnemonics on the chromatin

  2013cited by this paper
• Disassociation of Histone Deacetylase-3 from Normal Huntingtin Underlies Mutant Huntingtin Neurotoxicity

  2013cited by this paper
• Histone deacetylase-3 interacts with ataxin-7 and is altered in a spinocerebellar ataxia type 7 mouse model

  2013cited by this paper
• The Hereditary Ataxias

  2013cited by this paper
• Histone deacetylase 3 is required for maintenance of bone mass during aging.

  2013cited by this paper
• Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease

  2012cited by this paper
• Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.

  2012cited by this paper
• LANP mediates neuritic pathology in Spinocerebellar ataxia type 1.

  2012cited by this paper
• Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems.

  2012cited by this paper
• Lobule‐specific membrane excitability of cerebellar Purkinje cells

  2012cited by this paper
• HDAC inhibitor‐based therapies: Can we interpret the code?

  2012cited by this paper
• VEGF ameliorates the ataxic phenotype in spinocerebellar ataxia type 1 (SCA1) mice

  2011cited by this paper
• Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3β

  2011cited by this paper
• Spinocerebellar Ataxia Type 7 Cerebellar Disease Requires the Coordinated Action of Mutant Ataxin-7 in Neurons and Glia, and Displays Non-Cell-Autonomous Bergmann Glia Degeneration

  2011cited by this paper
• Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

  2010cited by this paper
• Histone Deacetylase 3 Depletion in Osteo/Chondroprogenitor Cells Decreases Bone Density and Increases Marrow Fat

  2010cited by this paper
• HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation

  2010cited by this paper
• Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions.

  2009cited by this paper
• Cerebellar cortical organization: a one-map hypothesis

  2009cited by this paper
• Haploinsufficiency of AFG3L2, the Gene Responsible for Spinocerebellar Ataxia Type 28, Causes Mitochondria-Mediated Purkinje Cell Dark Degeneration

  2009cited by this paper
• Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1*

  2009cited by this paper
• The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7

  2008cited by this paper
• The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice

  2008cited by this paper
• Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.

  2008cited by this paper
• Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

  2008cited by this paper
• Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice.

  2008cited by this paper
• Liver‐specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks

  2008cited by this paper
• Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse Model

  2007cited by this paper
• Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration

  2007cited by this paper
• HDAC3: taking the SMRT-N-CoRrect road to repression

  2007cited by this paper
• Distribution of histone deacetylases 1–11 in the rat brain

  2007cited by this paper
• Trinucleotide repeat disorders.

  2007cited by this paper
• Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation

  2006cited by this paper
• Differential Contributions of Caenorhabditis elegans Histone Deacetylases to Huntingtin Polyglutamine Toxicity

  2006cited by this paper
• Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport

  2006cited by this paper
• ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.

  2006cited by this paper
• The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.

  2005cited by this paper
• Patterned expression of Purkinje cell glutamate transporters controls synaptic plasticity

  2005cited by this paper
• Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice.

  2004cited by this paper
• Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors

  2004cited by this paper
• The N-CoR/Histone Deacetylase 3 Complex Is Required for Repression by Thyroid Hormone Receptor

  2003cited by this paper
• Patterned Purkinje cell death in the cerebellum.

  2003cited by this paper
• A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.

  2002cited by this paper
• The role of chaperones in polyglutamine disease.

  2002cited by this paper
• Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice.

  2001cited by this paper
• Identification of genes that modify ataxin-1-induced neurodegeneration

  2000cited by this paper
• Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.

  2000cited by this paper
• An alternative, nonapoptotic form of programmed cell death.

  2000cited by this paper
• Cre recombinase expression in cerebellar Purkinje cells

  2000cited by this paper
• Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1

  2000cited by this paper
• Generalized lacZ expression with the ROSA26 Cre reporter strain

  1999cited by this paper
• Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

  1998cited by this paper
• Signaling to chromatin through histone modifications: how clear is the signal?

  1998cited by this paper
• Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures

  1997cited by this paper
• Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics

  1997cited by this paper
• The compartmentalization of the cerebellum.

  1997cited by this paper
• Mapping of the Sca1 and pcd genes on mouse chromosome 13 provides evidence that they are different genes.

  1995cited by this paper
• SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

  1995cited by this paper
• CANNULATION OF RADIAL ARTERY

  1974cited by this paper
• Myxedema and ataxia

  1969cited by this paper
• Cerebellar syndrome in myxoedema.

  1960cited by this paper
• CEREBELLAR SYNDROME IN MYXŒDEMA

  1960cited by this paper

• Translational Relevance of SCA1 Models for the Development of Therapies for Spinocerebellar Ataxia Type 1

  2025influential citation
• Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias

  2025cites this paper
• Upregulated spinal histone deacetylases induce nociceptive sensitization by inhibiting the GABA system in chronic constriction injury–induced neuropathy in rats

  2024cites this paper
• Functional implications of paralog genes in polyglutamine spinocerebellar ataxias

  2023cites this paper
• Melatonin attenuates chronic sleep deprivation‐induced cognitive deficits and HDAC3‐Bmal1/clock interruption

  2023cites this paper
• Possible implication of miR-142-3p in coronary microembolization induced myocardial injury via ATXN1L/HDAC3/NOL3 axis

  2022cites this paper
• Reactive Bergmann glia play a central role in spinocerebellar ataxia inflammation via the JNK pathway

  2022cites this paper
• Developmental Alterations in Adult‐Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases

  2021cites this paper
• Ronin overexpression induces cerebellar degeneration in a mouse model of ataxia

  2021cites this paper
• Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy.

  2021cites this paper
• Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour

  2021cites this paper
• Early stage of Spinocerebellar Ataxia Type 1 (SCA1) progression exhibits region- and cell-specific pathology and is partially ameliorated by Brain Derived Neurotrophic Factor (BDNF)

  2021cites this paper
• Histone deacetylase in neuropathology.

  2021cites this paper
• Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.

  2020cites this paper
• Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion

  2020cites this paper
• Post-Translational Modifications in Neurodegeneration

  2020cites this paper
• Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice

  2020cites this paper
• Down‐regulated HDAC3 elevates microRNA‐495‐3p to restrain epithelial‐mesenchymal transition and oncogenicity of melanoma cells via reducing TRAF5

  2020cites this paper
• Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders.

  2020cites this paper
• SCA4 locus-associated gene Ronin (Thap11) increases Ataxin-1 protein levels and induces cerebellar degeneration in a mouse model of ataxia

  2020cites this paper
• Mutant ataxin 1 disrupts cerebellar development in spinocerebellar ataxia type 1

  2019cites this paper
• Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1

  2019cites this paper
• The impact of histone post-translational modifications in neurodegenerative diseases.

  2019cites this paper
• Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice

  2018cites this paper
• Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies

  2018cites this paper
• Epigenetic cerebellar diseases.

  2018cites this paper
• Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes.

  2018influential citation
• Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1

  2018cites this paper
• Complex neuroprotective and neurotoxic effects of histone deacetylases

  2018influential citation
• Tolerance of chronic HDACi-administration used for treatment of neurological and visceral disease including lung pathogenesis

  2017cites this paper
• Polyglutamine ataxias: From Clinical and Molecular Features to Current Therapeutic Strategies

  2017cites this paper
• Age-related alterations in histone deacetylase expression in Purkinje neurons of ethanol-fed rats.

  2017cites this paper
• Proteomic Analysis of HDAC3 Selective Inhibitor in the Regulation of Inflammatory Response of Primary Microglia

  2017cites this paper
• Gene, Stem Cell, and Alternative Therapies for SCA 1

  2016cites this paper
• Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1

  2016cites this paper
• Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model

  2016influential citation
• Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.

  2016cites this paper
• Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.

  2016cites this paper
• A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease.

  2016cites this paper
• Mechanisms underlying the neuroprotective effects of histone deacetylase inhibitors

  2015cites this paper
• Post-translational modifications in neurodegeneration

  2015cites this paper
• Complex Network-Driven View of Genomic Mechanisms Underlying Parkinson's Disease: Analyses in Dorsal Motor Vagal Nucleus, Locus Coeruleus, and Substantia Nigra

  2014cites this paper
• The promise and perils of HDAC inhibitors in neurodegeneration

  2014cites this paper
• Downregulation of Ca2+-Activated Cl− Channel TMEM16A by the Inhibition of Histone Deacetylase in TMEM16A-Expressing Cancer Cells

  2014cites this paper
• Downregulation of Ca 2 1-Activated Cl 2 Channel TMEM 16 A by the Inhibition of Histone Deacetylase in TMEM 16 A-Expressing Cancer Cells s

  2014cites this paper
• Identification of epigenomic patterns to annotate regulatory elements in the human genome

  2014cites this paper